Organic Process Research & Development 2006, 10, 799−802
A Practical Synthesis of 2-Arylamino-6-alkylaminopurines from
2,6-Dichloropurine
Lech Ciszewski, Liladhar Waykole,* Mahavir Prashad, and Oljan Repic´
Process R&D, Chemical and Analytical DeVelopment, NoVartis Pharmaceuticals Corporation, One Health Plaza,
East HanoVer, New Jersey 07936, U.S.A.
Scheme 1
Abstract:
A practical synthesis of N-[4-(6-cyclobutylamino-9H-purin-2-
ylamino)-phenyl]-N-methyl acetamide (QAB205, 5a), an anti-
asthmatic agent, is described from 2,6-dichloropurine (1) by
base-assisted substitution of the 6-chloro substituent with
cyclobutylamine (2a) followed by a new trimethylsilyl chloride-
catalyzed displacement of the 2-chloro group in intermediate
6-cycbutylamino-2-chloropurine (3a) with an aromatic amine.
Both steps can also be carried out in one pot without isolating
the intermediate 6-cyclobutylamino-2-chloropurine (3a). The
general synthetic utility of this route is demonstrated by
synthesizing several 2-arylamino-6-alkylaminopurines (5).
this paper we report a practical synthesis of 5a from 2,6-
dichloropurine (1) first by base-assisted substitution of the
6-chloro substituent with cyclobutylamine (2a), followed by
a new trimethylsilyl chloride catalyzed displacement of the
2-chloro group in intermediate 3a with 4a in n-butanol at
117 °C. Both of the steps can also be carried out sequentially
in one pot without isolating the intermediate 3a. The general
synthetic utility of this route is also demonstrated by
synthesizing several 2-arylamino-6-alkylaminopurines (Scheme
2).
Introduction
Purines and aminopurines are a pharmaceutically impor-
tant class of compounds. Recently, they have received a great
deal of attention due to their important physiological and
pharmacological properties.1 They are reported to have
potential as target nucleotide binding proteins that play a
significant role in many biological processes.2 They have
been reported to possess antirhinovirus activity.3 Also, purine
scaffolds have been shown to have antitumor activity as
kinase inhibitors.4 Therefore, a large number of purine
libraries have been synthesized using solid polymer supports
or in solution.5
N-[4-(6-Cyclobutylamino-9H-purin-2-ylamino)-phenyl]-
N-methyl acetamide (5a) is a potential antiasthmatic agent.1
While the synthesis of 5a was straightforward utilizing 2,6-
dichloropurine (1) as the starting material (Scheme 1), it was
necessary for us to optimize this synthesis for large-scale
preparation. Our main goals were to improve the displace-
ment of the 2-chloro substituent in intermediate (3a) with
4-N-methylacetanilidoaniline (4a) that required high tem-
perature (130 °C) and to possibly develop a one-pot
procedure from (1) to make the synthesis more efficient. In
Results and Discussion
Original conditions for the reaction of 1 with 2a involved
treatment of 1 (1 equiv) with 2a (2.0 equiv) in n-butanol at
55 °C for 16 h to afford 3a in 85% yield. Then, the reaction
of the resulting 3a with 4a (2.7 equiv) in NMP at 130 °C
over 6 h afforded the drug substance 5a in 81% yield as a
hemi-hydrochloride salt. These procedures suffered from
shortcomings such as irreproducibility, very high reaction
temperature, and difficult isolation and purification proce-
dures due to the use of excess amounts of 2a (2.0 equiv)
and 4a (2.7 equiv). Also the quality of the product was
unsatisfactory due to its dark color and contamination with
deacylated byproduct.
We focused on optimizing both the steps to achieve
operational efficiency. In the first step, use of an excess
amount (2 equiv) of the expensive cyclobutylamine 2a was
undesired. We found that the use of 1.1 equiv of 2a was
optimal when used with 1.1 equiv. of N,N-diisopropylethyl-
amine (DIEA) as an acid scavenger. Also, the reaction time
was shortened to 4.5 h when the reaction was carried out at
75 °C instead of 55 °C. Thus, to a mixture of 1 (1 equiv)
and N,N-diisopropylethylamine (1.1 equiv) in n-butanol at
75 °C was added a solution of 2a (1.1 equiv) in n-butanol
over 1 h. After the addition of 2a, the reaction mixture was
stirred at 75 °C for an additional 3.5 h. The reaction
proceeded smoothly and regioselectively as evidenced by
(1) Collingwood, S. P.; Hayler, J.; Le Grand, D. M.; Mattes, H.; Menear, K.
A.; Walker, C. V.; Cockcroft, X. L. WO 01/09134, February, 2001.
(2) Hurst, D. T. The Chemistry and Biology of Pyrimidines, Purines, and
Pteridines; Wiley: Chichester, U.K., 1980.
(3) Kelley, J. L.; Linn, J. A.; Krochamal, M. P.; Selway, J. W. T. J. Med. Chem.
1988, 31, 2001.
(4) (a) Garcia-Echeverria, C.; Taxler, P.; Evans, D. B. Med. Res. ReV. 2000,
20, 28 and references therein. (b) Schindler, T.; Bornmann, W.; Pellicena,
P.; Miller, W. T.; Claerkson, B.; Kuryan, J. Science 2000, 289, 1938 and
references therein.
(5) (a) Nugiel, D. A.; Lyndon A. M. C.; Corbett, J. W. J. Org. Chem. 1997,
62, 201-203 (b) Ding, S.; Gray, N. S.; Ding, Q.; Schultz J. Am. Chem.
Soc. 2001, 66, 8273-8276.
10.1021/op060053m CCC: $33.50 © 2006 American Chemical Society
Published on Web 06/02/2006
Vol. 10, No. 4, 2006 / Organic Process Research & Development
•
799